[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Diagnostics & Diseases Market Research Reports & Industry Analysis

Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).

A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.

This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.

Publications found: 42,324
Sort by:

2017 Brazil Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

... , including: Infectious Diseases Forensic Testing Cancer Paternity Testing/HLA Typing Genetic Diseases Others Five-year test volume and sales projections for ... molecular diagnostic analyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...

January 2017 1120 pages

2017 Chile Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

... , including: Infectious Diseases Forensic Testing Cancer Paternity Testing/HLA Typing Genetic Diseases Others Five-year test volume and sales projections for ... molecular diagnostic analyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...

January 2017 1120 pages

2017 China Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

... , including: Infectious Diseases Forensic Testing Cancer Paternity Testing/HLA Typing Genetic Diseases Others Five-year test volume and sales projections for ... molecular diagnostic analyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...

January 2017 1120 pages

2017 Colombia Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

... , including: Infectious Diseases Forensic Testing Cancer Paternity Testing/HLA Typing Genetic Diseases Others Five-year test volume and sales projections for ... molecular diagnostic analyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...

January 2017 1120 pages

2017 Croatia Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

... , including: Infectious Diseases Forensic Testing Cancer Paternity Testing/HLA Typing Genetic Diseases Others Five-year test volume and sales projections for ... molecular diagnostic analyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...

January 2017 1120 pages

2017 Hong Kong Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

This new report from VPGMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years. Highlights Five-year test volume and sales forecasts Feature comparison of major ...

January 2017 1120 pages

2017 India Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

... , including: Infectious Diseases Forensic Testing Cancer Paternity Testing/HLA Typing Genetic Diseases Others Five-year test volume and sales projections for ... molecular diagnostic analyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...

January 2017 1120 pages

2017 Indonesia Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

... , including: Infectious Diseases Forensic Testing Cancer Paternity Testing/HLA Typing Genetic Diseases Others Five-year test volume and sales projections for ... molecular diagnostic analyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...

January 2017 1120 pages

2017 Iran Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

... , including: Infectious Diseases Forensic Testing Cancer Paternity Testing/HLA Typing Genetic Diseases Others Five-year test volume and sales projections for ... molecular diagnostic analyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...

January 2017 1120 pages

2017 Iraq Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

... , including: Infectious Diseases Forensic Testing Cancer Paternity Testing/HLA Typing Genetic Diseases Others Five-year test volume and sales projections for ... molecular diagnostic analyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...

January 2017 1120 pages

2017 Israel Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

... , including: Infectious Diseases Forensic Testing Cancer Paternity Testing/HLA Typing Genetic Diseases Others Five-year test volume and sales projections for ... molecular diagnostic analyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...

January 2017 1120 pages

2017 Jordan Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

... , including: Infectious Diseases Forensic Testing Cancer Paternity Testing/HLA Typing Genetic Diseases Others Five-year test volume and sales projections for ... molecular diagnostic analyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...

January 2017 1120 pages

2017 Kuwait Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

... , including: Infectious Diseases Forensic Testing Cancer Paternity Testing/HLA Typing Genetic Diseases Others Five-year test volume and sales projections for ... molecular diagnostic analyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...

January 2017 1120 pages

2017 Lebanon Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

... , including: Infectious Diseases Forensic Testing Cancer Paternity Testing/HLA Typing Genetic Diseases Others Five-year test volume and sales projections for ... molecular diagnostic analyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...

January 2017 1120 pages

2017 Malaysia Tumor Marker Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

... consumable suppliers Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five ... 30 NAT assays. Product/Technology Review Comparison of leading molecular diagnostic analyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing ...

January 2017 1120 pages

2017 Mexico Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

... , including: Infectious Diseases Forensic Testing Cancer Paternity Testing/HLA Typing Genetic Diseases Others Five-year test volume and sales projections for ... molecular diagnostic analyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...

January 2017 1120 pages

2017 Myanmar Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

... , including: Infectious Diseases Forensic Testing Cancer Paternity Testing/HLA Typing Genetic Diseases Others Five-year test volume and sales projections for ... molecular diagnostic analyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...

January 2017 1120 pages

2017 New Zealand Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

... are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with ... portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D. Opportunities and Strategic Recommendations New product development opportunities with potentially significant ...

January 2017 1120 pages

2017 Oman Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

... , including: Infectious Diseases Forensic Testing Cancer Paternity Testing/HLA Typing Genetic Diseases Others Five-year test volume and sales projections for ... molecular diagnostic analyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...

January 2017 1120 pages

2017 Pakistan Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

... , including: Infectious Diseases Forensic Testing Cancer Paternity Testing/HLA Typing Genetic Diseases Others Five-year test volume and sales projections for ... molecular diagnostic analyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...

January 2017 1120 pages

2017 Peru Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

... , including: Infectious Diseases Forensic Testing Cancer Paternity Testing/HLA Typing Genetic Diseases Others Five-year test volume and sales projections for ... molecular diagnostic analyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...

January 2017 1120 pages

2017 Philippines Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

... , including: Infectious Diseases Forensic Testing Cancer Paternity Testing/HLA Typing Genetic Diseases Others Five-year test volume and sales projections for ... molecular diagnostic analyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...

January 2017 1120 pages

2017 Qatar Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

... , including: Infectious Diseases Forensic Testing Cancer Paternity Testing/HLA Typing Genetic Diseases Others Five-year test volume and sales projections for ... molecular diagnostic analyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...

January 2017 1120 pages

2017 Saudi Arabia Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

This new report from VPGMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years. Highlights Five-year test volume and sales forecasts Feature comparison of major ...

January 2017 1120 pages

2017 Serbia Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

... , including: Infectious Diseases Forensic Testing Cancer Paternity Testing/HLA Typing Genetic Diseases Others Five-year test volume and sales projections for ... molecular diagnostic analyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...

January 2017 1120 pages

2017 Singapore Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

... , including: Infectious Diseases Forensic Testing Cancer Paternity Testing/HLA Typing Genetic Diseases Others Five-year test volume and sales projections for ... molecular diagnostic analyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...

January 2017 1120 pages

2017 South Korea Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

This new report from VPGMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years. Highlights Five-year test volume and sales forecasts Feature comparison of major ...

January 2017 1120 pages

2017 Taiwan Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

... , including: Infectious Diseases Forensic Testing Cancer Paternity Testing/HLA Typing Genetic Diseases Others Five-year test volume and sales projections for ... molecular diagnostic analyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...

January 2017 1120 pages

2017 Thailand Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

... , including: Infectious Diseases Forensic Testing Cancer Paternity Testing/HLA Typing Genetic Diseases Others Five-year test volume and sales projections for ... molecular diagnostic analyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...

January 2017 1120 pages

2017 United Arab Emirates Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

This new report from VPGMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years. Highlights Five-year test volume and sales forecasts Feature comparison of major ...

January 2017 1120 pages

2017 Venezuela Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

... , including: Infectious Diseases Forensic Testing Cancer Paternity Testing/HLA Typing Genetic Diseases Others Five-year test volume and sales projections for ... molecular diagnostic analyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...

January 2017 1120 pages

2017 Vietnam Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

US$ 3,825.00

... , including: Infectious Diseases Forensic Testing Cancer Paternity Testing/HLA Typing Genetic Diseases Others Five-year test volume and sales projections for ... molecular diagnostic analyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...

January 2017 1120 pages

2018 Argentina Molecular Diagnostic Analyzers and Reagents: Molecular Diagnostic Analyzers and Reagents: Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing--Supplier Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation Review

US$ 4,250.00

... for over 30 NAT assays Product/Technology Review Comparison of leading molecular diagnostic analyzers.- Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation ...

January 2017 1120 pages

2018 Bahrain Molecular Diagnostic Analyzers and Reagents: Molecular Diagnostic Analyzers and Reagents: Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing--Supplier Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation Review

US$ 4,250.00

... for over 30 NAT assays Product/Technology Review Comparison of leading molecular diagnostic analyzers.- Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation ...

January 2017 1120 pages

2017 Middle East Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

US$ 22,050.00

... new report from VPGMarketResearch.com provides granular analysis of the Middle East diagnostic testing market, including Bahrain, Iran, Iraq, Israel, Jordan, Kuwait, Lebanon ... market segments: Blood Banking Cancer Diagnostics Chemistry Coagulation Drugs of Abuse Endocrine Function Hematology and Flow Cytometry Immunoprotein Infectious Diseases Molecular Diagnostics ...

January 2017 410 pages

2017 Latin America Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

US$ 15,750.00

... new report from VPGMarketResearch.com provides granular analysis of the Latin America diagnostic testing market, including Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela ... market segments: Blood Banking Cancer Diagnostics Chemistry Coagulation Drugs of Abuse Endocrine Function Hematology and Flow Cytometry Immunoprotein Infectious Diseases Molecular Diagnostics ...

January 2017 260 pages

Cervical Cancer Test Market & Patients (Pap Smear, HPV DNA, VIA) in Asia (Japan, Korea, Singapore, Malaysia, India, China, Thailand, Indonesia)

US$ 1,250.00

... the growth of cervical cancer test market in the developing countries. Cervical Cancer Test Market & Patients (Pap Smear, HPV DNA, VIA) in Asia (Japan, Korea, Singapore, Malaysia, India, China, Thailand, Indonesia) report published by Renub Research provides a comprehensive analysis of this market and future ...

January 2017 121 pages

2017 Argentina Cancer Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers

US$ 4,365.00

... opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... major cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the ...

January 2017 535 pages

2017 Bahrain Cancer Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers

US$ 4,365.00

... opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... major cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the ...

January 2017 535 pages

2017 Bangladesh Cancer Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers

US$ 4,365.00

... opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... major cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the ...

January 2017 535 pages

2017 Brazil Cancer Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers

US$ 4,365.00

... opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... major cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the ...

January 2017 535 pages

2017 Chile Cancer Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers

US$ 4,365.00

... opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... major cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the ...

January 2017 535 pages

2017 China Cancer Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers

US$ 4,365.00

... opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... major cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the ...

January 2017 535 pages

2017 Colombia Republic Cancer Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers

US$ 4,365.00

... opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging tests; analyzes potential applications of innovative technologies; forecasts volume and sales for major cancer diagnostics tests ...

January 2017 535 pages

2017 Croatia Cancer Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers

US$ 4,365.00

... opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... major cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the ...

January 2017 535 pages

2017 Egypt Cancer Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers

US$ 4,365.00

... opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... major cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the ...

January 2017 535 pages

2017 Ghana Cancer Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers

US$ 4,365.00

... opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... major cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the ...

January 2017 535 pages

2017 Hong Kong Cancer Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers

US$ 4,365.00

... opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging tests; analyzes potential applications of innovative technologies; forecasts volume and sales for major cancer diagnostics tests ...

January 2017 535 pages

2017 India Cancer Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers

US$ 4,365.00

... opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... major cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the ...

January 2017 535 pages

2017 Indonesia Cancer Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers

US$ 4,365.00

... opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... major cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the ...

January 2017 535 pages

Filters

Search

Categories

675
84
1,065
32,618
152
69
819
657
1,864
4,251
70

Publishers

8
9
35
1
15
4
40
1
1
17
12
4
1
1
13
2
1
53
1
1
9
9
328
1
2
1
5
16
1
1
13
4
40
1
2
8
5
16
19
36
7
10
6
2
3
174
108
13
53
3
29
15
1
4
7
18
3
24
3
32
1
15
2
7
2
81
47
11
77
1
14
2
22
3
74
40,224
1
40
2
17
15
24
85
6
10
50
11
62
48
1
45
23
49

Regions

281
15
1
135
138
138
138
137
136
136
135
132
131
179
38
15,330
450
193
192
192
138
4
3
2
199
198
197
197
197
196
195
195
195
193
106
194
196
195
193
107
197
139
204
195
190
201
199
197
139
105
196
195
195
195
196
177
200
198
139
112
198
198
196
196
194
194
139
139
136
136
136
1
1
201
199
198
196
195
199
197
197
196
196
196
195
195
195
196
196
193
139
139
138
108
16
1
1
199
1
108
1,216
1,214
1,198
1,193
1,173
246
2
264
195
196
204
198
1,228
1,153
1,669

Price

Date

Pages

Offers

33
6
1
15
84